Read about Samsung Biologic’s monumental decision to invest $2 billion in a “Super Plant” for biomanufacturing and pharmaceuticals.
Read and learn about Meet Delic’s past virtual event on how to grow a psychedelic business in this emerging industry.
Are you curious if mushrooms will follow in marijuana’s footsteps? Read to learn about how the U.S. is moving to decriminalize psilocybin.
Read about Meet Delic’s past virtual event on how ketamine serves as a therapeutic for people suffering from ‘treatment-resistant’ depression.
Researchers from the Norwegian University of Science and Technology published a population study on psychedelic use and mental health.
The Entheogenic Plant and Fungus Policy Act – Initiative 81 is on the road to decriminalizing plant medicines in D.C.